Home
Newsletter
Events
Blogs
Reports
Graphics
RSS
About Us
Contact Us
Write for Us
Media Info
Advertising Info

Search Results


FDA approves controversial drug for use against Alzheimer's disease, despite evidence showing it doesn't work

https://naturalnews.com/2021-07-02-fda-approves-controversial-alzheimers-drug.html

The drug, known as aducanumab, is the first Alzheimer’s treatment approved by the FDA in almost 20 years. ... Biogen is also charging $56,000 per year for aducanumab. It is meant to be given as an infusion every four weeks. "...

ICER: FDA failed to protect patients from unproven Alzheimer's treatment with known harms

https://naturalnews.com/2021-06-13-fda-failed-to-protect-alzheimers-patients-from-harm.html

It allows the drug scientifically known as aducanumab to be prescribed and used while its maker Biogen conducts a post-marketing, phase 4 confirmatory study that could take years to complete. ... “FDA approval closes the door on further placebo-controlled trials of aducanumab that might have helped to resolve disputes about efficacy quickly and cleanly,” Howard said. "...